Get started
Author

Chiara Lonigro

Customized protein glycosylation to improve biopharmaceutical function and targeting
2018 · Linde Van Landuyt, Chiara Lonigro, et al. · Current Opinion in Biotechnology · 70
An affinity-enhanced, broadly neutralizing heavy chain–only antibody protects against SARS-CoV-2 infection in animal models
2021 · Bert Schepens, Loes van Schie, et al. · Science Translational Medicine · 66
OPENPichia: licence-free Komagataella phaffii chassis strains and toolkit for protein expression
2024 · Katrien Claes, Dries Van Herpe, et al. · Nature Microbiology · 44
PDF
Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base
2025 · Sieglinde De Cae, Inge Van Molle, et al. · Nature Communications · 18
PDF
From the Amelioration of a NADP+‐dependent Formate Dehydrogenase to the Discovery of a New Enzyme: Round Trip from Theory to Practice
2020 · Marina Simona Robescu, Rudy Rubini, et al. · ChemCatChem · 17
OPENPichia: building a free-to-operate Komagataella phaffii protein expression toolkit
2022 · Dries Van Herpe, Robin Vanluchene, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 4
PDF
Yeast-based production platform for potent and stable heavy chain-only antibodies
2024 · Chiara Lonigro, Hannah Eeckhaut, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Algal chloroplasts for in vivo screening an in vitro evolved library from a bacterial FDH: a proof-of-concept experiment.
2017 · Elisa Beneventi, Chiara Lonigro, et al. · Padua Research Archive (University of Padova)
On the Route of Biocatalysts: in vivo Selection in Chlamydomonas Chloroplasts for an in vitro Evolved Bacterial Formate Dehydrogenase
2017 · Elisa Beneventi, Chiara Lonigro, et al. · Padua Research Archive (University of Padova)
PDF
Works count: 10
Citation count: 219
H-index: 5
I10-index: 5
Year
Topic
Type